Tuesday, June 1, 2021

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug Lilly said it is engaged in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with COVID-19.

from Moneycontrol Business News https://ift.tt/3p6Q9cZ

No comments:

Post a Comment

Zepto IPO, Swiggy QIP bad news for Eternal investors? Jefferies analysts decode

Jefferies has reiterated its Buy rating on Eternal with a target price of Rs 480, citing strong growth prospects, improving unit economics a...